TOPLINE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors may surpass other oral antidiabetic drugs in metabolic dysfunction–associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease […]

COPENHAGEN (Reuters) -Novo Nordisk on Thursday surpassed Tesla Inc in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data […]

TOPLINE: Home or hospital insulin pumps are safe and improve glucose control in pediatric, adolescent, and young adult patients with type 1 diabetes hospitalized for noncritical […]

TOPLINE: A fiber supplement also found in beans and other foods may lead to weight loss and improved insulin sensitivity in people with excess body weight, […]

TOPLINE: Men with low birth weight who go on to be overweight in young adulthood have a nearly 10-fold increased risk of developing type 2 diabetes, […]

Once again, in the face of the ongoing shortage of anti-obesity medicines (AOMs), the US Food and Drug Administration (FDA) has warned against using compounded versions […]

The US Food and Drug Administration (FDA) has cleared Dexcom’s Stelo Glucose Biosensor System as the first over-the-counter continuous glucose monitoring (CGM) system. Unlike Dexcom’s G6 […]

While TikTok overflows with images of influencers making “adrenal cocktails” to combat what they call adrenal fatigue, the Endocrine Society says “no scientific proof exists to […]

COPENHAGEN (Reuters) – Novo Nordisk’s widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the […]